CY1113762T1 - TOSSULIC SALT OF A THERAPEUTIC UNION AND ITS PHARMACEUTICAL COMPOSITIONS - Google Patents
TOSSULIC SALT OF A THERAPEUTIC UNION AND ITS PHARMACEUTICAL COMPOSITIONSInfo
- Publication number
- CY1113762T1 CY1113762T1 CY20121101105T CY121101105T CY1113762T1 CY 1113762 T1 CY1113762 T1 CY 1113762T1 CY 20121101105 T CY20121101105 T CY 20121101105T CY 121101105 T CY121101105 T CY 121101105T CY 1113762 T1 CY1113762 T1 CY 1113762T1
- Authority
- CY
- Cyprus
- Prior art keywords
- disorders
- congestion
- pharmaceutical compositions
- allergies
- fluoro
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Η παρούσα εφεύρεση αφορά στο τοσυλικό άλας του trans-Ν-αιθυλ-3-φθορο-3-[3-φθορο-4-(πυρρολιδιν-1-υλμεθυλ)-φαινυλ]-κυκλοβουτανοκαρβοξαμιδίου (1): σε επιδιαλυτωμένα άλατα (π.χ. υδρίτες) αυτού, σε πολύμορφα αυτού, σε φαρμακευτικές συνθέσεις αυτού και σε μια μέθοδο θεραπείας της κατάθλιψης, διαταραχών της διάθεσης, σχιζοφρένειας, διαταραχών άγχους, νοητικών διαταραχών, της νόσου του Alzheimer, της διαταραχής ελλειμματικής προσοχής (ADD), του ελλείμματος προσοχής υπερκινητικότητας (ADHD) , ψυχωτικών διαταραχών, διαταραχών του ύπνου, παχυσαρκίας, ζάλης, επιληψίας, ναυτίας, αναπνευστικών ασθενειών, αλλεργίας, αποκρίσεις των αεραγωγών που προκαλούνται από αλλεργίες, αλλεργικής ρινίτιδας, ρινικής συμφόρησης, αλλεργικής συμφόρησης, συμφόρησης, υπότασης, καρδιαγγειακής νόσου, ασθενειών του γαστρεντερικού σωλήνα, υπερ- και υπο-κινητικότητας και όξινης έκκρισης του γαστρεντερικού σωλήνα, η οποία περιλαμβάνει την χορήγηση μιας θεραπευτικά αποτελεσματικής ποσότητας αυτών.The present invention relates to the tosylate of trans-N-ethyl-3-fluoro-3- [3-fluoro-4- (pyrrolidin-1-ylmethyl) -phenyl] -cyclobutanecarboxamide (1): in solvates (e.g. hydrates), polymorphs, pharmaceutical compositions, and a method of treating depression, mood disorders, schizophrenia, anxiety disorders, mental disorders, Alzheimer's disease, Attention Deficit Disorder (ADD), Attention Deficit Hyperactivity Disorder (ADHD), psychotic disorders, sleep disorders, obesity, dizziness, epilepsy, n cause, respiratory diseases, allergies, airway responses caused by allergies, allergic rhinitis, nasal congestion, allergic congestion, congestion, hypotension, cardiovascular disease, gastrointestinal tract diseases, hypertriglyceridemia and hypoxicemia which comprises administering a therapeutically effective amount thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88593107A | 2007-01-22 | 2007-01-22 | |
| EP08702250A EP2124933B1 (en) | 2007-01-22 | 2008-01-10 | Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1113762T1 true CY1113762T1 (en) | 2016-07-27 |
Family
ID=57102335
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20121101105T CY1113762T1 (en) | 2007-01-22 | 2012-11-16 | TOSSULIC SALT OF A THERAPEUTIC UNION AND ITS PHARMACEUTICAL COMPOSITIONS |
Country Status (1)
| Country | Link |
|---|---|
| CY (1) | CY1113762T1 (en) |
-
2012
- 2012-11-16 CY CY20121101105T patent/CY1113762T1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2009007782A (en) | Tosylate salt of a therapeutic compound and pharmaceutical compositions thereof. | |
| ATE488496T1 (en) | HISTAMINE 3 RECEPTOR ANTAGONISTS | |
| UY29882A1 (en) | HISTAMINE RECEIVER 3 ANTAGONISTS | |
| WO2007063385A3 (en) | Spirocyclic amine histamine-3 receptor antagonists | |
| WO2007105053A3 (en) | Tetralines antagonists of the h-3 receptor | |
| BRPI0507374A (en) | histamine-3 receptor modulators | |
| MA32898B1 (en) | POSITIVE ALLOSTERIC MODULATORS OF ARYLMETHYLBENZOQUINAZOLINONE M1 RECEPTOR | |
| ECSP10010156A (en) | PIPERIDINO-DIHIDROTIENOPIRIMIDINAS REPLACED | |
| ATE524450T1 (en) | 5-PHENYL-ISOXAZOLE-3-CARBOXAMIDE DERIVATIVES AS TRPV1 MODULATORS | |
| EA201100423A1 (en) | NEW BENZAMIDES, THEIR PRODUCTION AND THEIR APPLICATION AS A MEDICINE | |
| DE502005010170D1 (en) | NEW LOW-ACTIVE BETA-2 AGONISTS AND THEIR USE AS DRUGS | |
| CY1111287T1 (en) | USE OF AGOMELATIN FOR TAKING MEDICINES INTENDED FOR TREATMENT OF GENERAL ANXIETY DISORDER | |
| CY1108104T1 (en) | (4-Methoxy-7-morpholin-4-yl-benzothiothiazol-2-yl) Amide of 4-hydroxy-4-methyl-piperidine-1-carboxylic acid | |
| EA016687B8 (en) | Cyclopropyl amide derivatives | |
| CY1114877T1 (en) | PYRAZOLI FINISH PRODUCTS | |
| BRPI0516079A (en) | histamine-3 receptor antagonists | |
| MX2010006162A (en) | Tosylate salt of trans-n-isobutyl-3-fluoro-3- [3-flu0r0-4- (pyrrolidin-1-yl-methyl) -phenyl] cyclobut anecarboxamide. | |
| PH12014501293A1 (en) | Phenylpyrrole derivative | |
| CY1113762T1 (en) | TOSSULIC SALT OF A THERAPEUTIC UNION AND ITS PHARMACEUTICAL COMPOSITIONS | |
| JP2009161517A5 (en) | ||
| CY1114789T1 (en) | COMPETITIVES HISTAMIN RECEPTORS-3 | |
| CY1113392T1 (en) | NEW CRYSTAL FORMS OF TIOTROPIO BRUMIDE | |
| CU20070070A7 (en) | PHARMACEUTICAL COMPOSITION OF AGOMELATIN | |
| TH120271A (en) | Dihydroquinolone derivatives | |
| TH88617B (en) | Histamine-3 receptor antagonist |